Company Filing History:
Years Active: 2015
Title: Sandra Seidl - Innovator in Cancer Treatment
Introduction
Sandra Seidl is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on enhancing the immune response to combat cancer effectively.
Latest Patents
Sandra Seidl holds a patent for "SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer." This invention relates to a method for the immune activation of NK cells by reducing or inhibiting the Cbl-b function in these cells. This approach stimulates the innate immune system, allowing for the therapy of relevant diseases. She has 1 patent to her name.
Career Highlights
Sandra is associated with Apeiron Biologics AG, a company dedicated to developing innovative immunotherapies. Her role in the company has been pivotal in advancing research that aims to improve cancer treatment options.
Collaborations
Throughout her career, Sandra has collaborated with notable colleagues, including Günther Lametschwandtner and Hans Loibner. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in cancer therapy.
Conclusion
Sandra Seidl's contributions to cancer treatment through her innovative patent and collaborative efforts highlight her importance in the field of medical research. Her work continues to inspire advancements in immunotherapy and cancer care.